Global Wealth Strategies & Associates Editas Medicine, Inc. Transaction History
Global Wealth Strategies & Associates
- $389 Billion
- Q3 2025
A detailed history of Global Wealth Strategies & Associates transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Global Wealth Strategies & Associates holds 160 shares of EDIT stock, worth $627. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160
Previous 125
28.0%
Holding current value
$627
Previous $275,000
101.82%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
45.5MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$30.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$28.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$7.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$7.36 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$7.24 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $269M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...